HAIFA, Israel, March 20 /PRNewswire/ -- InSightec Ltd., the company that developed and markets the ExAblate(R) 2000 Magnetic Resonance guided Focused Ultrasound (MRgFUS) incisionless surgery system, announced today that Red Herring magazine has named the company to its Red Herring 100 Europe 2007 list of the top privately-held technology companies in Europe, the Middle East and Africa (EMEA).
“InSightec is honored to receive this prestigious award that further validates the company’s innovation and efforts to reduce the need for invasive surgery,” said Kobi Vortman, president and CEO of InSightec. “MRgFUS technology provides patients and physician with a non-invasive treatment alternative that has the potential to replace traditional surgery with a non-invasive one, reducing trauma and morbidity to millions of patients around the world. The wide spectrum of potential clinical applications that could benefit from this technology and the excellent preliminary research results in many clinical applications will help transform today’s surgical environment and create the next generation operating room.”
Red Herring’s lists of top private companies are an important part of the company’s tradition of identifying new and innovative technology companies and entrepreneurs. Companies like Google, eBay and Skype were spotted in their early days by Red Herring editors, and touted as leaders that would change the way we live and work.
Red Herring’s editorial staff rigorously evaluated entrepreneurial companies in a careful analysis of financial data and subjective criteria, including quality of management, execution of strategy, and dedication to research and development.
About ExAblate 2000
The ExAblate 2000 is the first system to use the breakthrough MRgFUS technology that combines MRI - to visualize tissues in the body, plan the treatment and monitor in real time treatment outcome - and high intensity focused ultrasound to thermally ablate uterine fibroid tissue. MR thermal feedback, provided uniquely by the system, allows the physician to control and adjust the treatment in real time to ensure that the targeted tumor is fully treated and surrounding tissue is spared. ExAblate received FDA approval for the treatment of symptomatic uterine fibroids in October 2004. ExAblate has been recognized for its innovation and potential to serve mankind and has been awarded the 2004 European Union’s Information Society Technologies grand prize, The Wall Street Journal’s 2004 Technology Innovation Awards, and Advanced Imaging’s 2005 Solutions of the Year.
When the U.S. Food and Drug Administration (FDA) approved the company’s ExAblate 2000 MRgFUS system in 2004, it became - and remains today - the only non-invasive treatment option for women with symptomatic uterine fibroids. Currently, the company is involved in clinical trials applying the non-invasive treatment paradigm to breast, liver, bone and brain tumors.
About InSightec
InSightec Ltd. is a privately held company owned by Elbit Medical Imaging (EMI), General Electric, MediTech Advisors, LLC and employees. It was founded in 1999 to develop the breakthrough MR guided Focused Ultrasound technology and transform it into the next generation operating room. Headquartered near Haifa, Israel, the company has over 135 employees and has invested more than $100 million in research, development, and clinical investigations. Its U.S. headquarters are located in Dallas, Texas. For more information, please go to: http://www.insightec.com/
About Red Herring
Red Herring, Inc., founded in 1993, is a media company focused on innovation, technology, financing and entrepreneurial activity. Red Herring has held the top 100 competition since 1996, identifying new and promising technology companies and entrepreneurs, as well as breakthrough technologies for tomorrow.
Contact Information InSightec Ltd. http://www.insightec.com/ Tel: +972-4-813-1313 Email: info@insightec.com For media inquiries: Fern Lazar Lazar Partners, Ltd. Tel: +972-212-867-1762 Email: flazar@lazarpartners.com
InSightec Ltd
CONTACT: Contact Information: InSightec Ltd., Tel: +972-4-813-1313, Email:info@insightec.com; For media inquiries: Fern Lazar, Lazar Partners, Ltd.,Tel: +972-212-867-1762, Email: flazar@lazarpartners.com
